This kinase inhibitor hits the VEGFR, PDGFR, and RAF kinases, It’s good for kidney, liver, and some thyroid cancers. The form is a tablet, coated and each one’s 200 milligrams; You take it 400 mg, twice a day which adds up to 800 mg per day; It’s prescribed for more serious kidney, some liver, and iodine-resistant thyroid cancers; On an empty stomach is the way to go; comes in a bottle with 120 tablets.
The inhibitor shows a punch against different bad-kid genes that cancers use and shuts ’em down. They’ve given the OK to use it for kidney cancer that has spread and is more severe and They’re also looking into it for liver and thyroid cancers.
Reviews
There are no reviews yet.